David Kotlyar

1.6k citations
29 papers · 1.0k indexed · h-index 11

Impact in

Papers in

David Kotlyar

26 papers receiving 990 citations

Peers

David Kotlyar
Comparison fields: 5 of 72
  • Hepatology 265
  • Transplantation 79
  • Genetics 517
  • Epidemiology 510
  • Toxicology 36
Replace Trevor Lissoos with:
Trevor Lissoos United States
Richard A. Willson United States
Michael J. Burt New Zealand
Bernd Kaskas Germany
Yago González‐Lama Spain
Spiros Delis Greece
D. H. Present United States
D Forti Italy
Esther García-Planella Spain
William E. Beschorner United States
David Kotlyar relative to Trevor Lissoos United States Trevor Lissoos's profile →
Citations per field
00.5×10×15×18×
Trevor Lissoos · 1×
Citations per year

Countries citing papers authored by David Kotlyar

Since Specialization
Citations

This map shows the geographic impact of David Kotlyar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kotlyar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kotlyar more than expected).

Fields of papers citing papers by David Kotlyar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kotlyar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kotlyar. The network helps show where David Kotlyar may publish in the future.

Co-authors

The 25 scholars most cited alongside David Kotlyar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Kotlyar Line = papers co-authored together David Kotlyar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20240
3 20161
4 201422
5 2014274
6 201310
7 20122
8 201117
9 201158
10 20112
11 20113
12 20112
13 2010310
14 20101
15 201029
16 20091
17 20088
18 200873
19 20081
20 2005134

About David Kotlyar

David Kotlyar is a scholar working on Genetics, Pathology and Forensic Medicine, Hepatology, Epidemiology and Oncology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Inflammatory Bowel Disease (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers), Viral-associated cancers and disorders (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Microscopic Colitis (4 papers). The work is most often cited by research in Hepatology (265 citations), Transplantation (79 citations), Genetics (517 citations), Epidemiology (510 citations) and Toxicology (36 citations). David Kotlyar has collaborated with scholars based in United States, Poland and Spain. Frequent co-authors include Wojciech Błoński, Gary R. Lichtenstein, Mical S. Campbell, Mariusz A. Wasik, Robert H. Diamond, Ming Lin, Manuel Mendizábal, David L. Porter, James D. Lewis and Mark T. Osterman. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology, Addiction Biology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026